Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer
This study has been terminated.
(Study shut-down in 12/2010 when NeoPharm merged with Insys.)
Sponsor:
Insys Therapeutics Inc
Information provided by:
Insys Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT01188408
First received: August 19, 2010
Last updated: June 2, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | September 2011 (Final data collection date for primary outcome measure) |